ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE (ESPE 2015)

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Category 3

GH & IGF

Previous section
Fat
Table of contents
Next section
Gonads

hrp0084p3-916 | GH & IGF

Vitamin D Deficiency can Modulate GH/IGF1 Axis in GH Deficient Children

hrp0084p3-917 | GH & IGF

Serum IGFI Concentration and Growth During Infancy Correlate to Polyunsaturated Fatty Acid Pattern

hrp0084p3-918 | GH & IGF

Are Short Children with Low GH Secretion Metabolically Different from Children of Normal Height?

hrp0084p3-919 | GH & IGF

Familial Short Stature Associated to Terminal Microdeletion of 15q26.3: Variable Phenotype not Involving the IGF1 Receptor Gene

hrp0084p3-920 | GH & IGF

Is the Insulin Secretion in Pancreatic Beta Cells Related with IGF-1/IGFBP-1 Axis in Korean Children?

hrp0084p3-921 | GH & IGF

Severe Isolated Growth Hormone Deficiency and Myopathy in Two Brothers with RNPC3 Mutation

hrp0084p3-922 | GH & IGF

Gigantism Secondary to Growth Hormone Secreting Pituitary Macrodenoma

hrp0084p3-923 | GH & IGF

IGFI and Relation to Growth in Infancy and Early Childhood in Very-Low-Birth-Weight Infants and Term Appropriate for Gestational Age Infants

hrp0084p3-924 | GH & IGF

Severe Isolated Growth Hormone Deficiency and Myopathy in Two Brothers With RNPC3 Mutation

hrp0084p3-925 | GH & IGF

Influence of the -202 A/C IGFBP3 Promoter Polymorphism on Individual Variation in Body Height in Korean Girls

hrp0084p3-926 | GH & IGF

Usefulness of Priming with Gonadal Steroids Prior to GH Stimulation with Clonidine in the Evaluation of the GH Status of Short Children

hrp0084p3-927 | GH & IGF

Comparison of Two IGF1 Assays in Patients Treated with GH

hrp0084p3-928 | GH & IGF

Acute Effects of a Training Session on IGF1 and IGFBP3 Concentrations in Brazilian Jiu-Jitsu Fighters

hrp0084p3-929 | GH & IGF

Biochemical Profiles Differentials by SGA Children Catch Up

hrp0084p3-930 | GH & IGF

IGF1 Deficiency: An Important Differential Diagnosis in Severe Growth Failure and Its Excellent Response to rhIGF1 Replacement Therapy

hrp0084p3-931 | GH & IGF

5-Year Response to GH in Children with Noonan Syndrome and GH Deficiency: Our Experience and Review of the Literature

hrp0084p3-932 | GH & IGF

Modification of Cardiovascular Risk Factors in Children Treated with GH

hrp0084p3-933 | GH & IGF

Adult Height in Children Born Small for Gestational Age and Treated with GH: Data from the French KIGS Database

hrp0084p3-934 | GH & IGF

Psychosocial Functioning and Self-Perception of Children and Adolescents Treated with GH

hrp0084p3-935 | GH & IGF

Do IGF1 Generation Test Results Predict 1st-Year Growth Response to GH Treatment in Idiopathic Short Stature?

hrp0084p3-936 | GH & IGF

Adherence to GH Treatment: Impact of Actual Height, Treatment Duration, and Puberty

hrp0084p3-937 | GH & IGF

The Blood Oxidant System and Insulin Resistance in Girls with Turner Syndrome after 1 Year of GH Therapy

hrp0084p3-938 | GH & IGF

An Open-Label Phase 2 Dose-Finding Study Comparing Three Different Doses of Weekly TV-1106 and Daily Recombinant Human GH (Genotropin®) in Treatment-Naive, Pre-Pubertal, GH-Deficient Children

hrp0084p3-939 | GH & IGF

Increasing Lean Body Mass, Phase Angle, and Total Body Water But Decreasing Body Fat Among Short-statured Children Born Small-for-Gestational Age on GH Treatment

hrp0084p3-940 | GH & IGF

GH Dosing Patterns in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency Enrolled in the NordiNet® International Outcome Study

hrp0084p3-941 | GH & IGF

Decrease of Small Dense LDL and Lipoprotein-Associated Phospholipase A2 due to Human GH Treatment in Short Children with GH Deficiency and Small for Gestational Age Status

hrp0084p3-942 | GH & IGF

Long-Term Insulin Sensitivity and β-Cell Function in Short Children Born Small for Gestational Age Treated with GH and GnRHa: Results of a Randomised, Dose-response Trial

hrp0084p3-943 | GH & IGF

Influence of the Application of the POI Score on the Results of GH Therapy in Prader-Willi

hrp0084p3-944 | GH & IGF

The Impact of GH Therapy in Noonan Syndrome Children with Identified Mutations in RAS/MAPK Pathway

hrp0084p3-945 | GH & IGF

As Great Intra as Interindividual Variability in Uptake of s.c. GH Injections in Longitudinally Followed GH Treated Children

hrp0084p3-946 | GH & IGF

The Correlation between the Increase in IGF1 and the Growth Improvement Induced by GH Treatment in Short Children Born Small for Gestational Age

hrp0084p3-947 | GH & IGF

Medical and Biochemical Effects of Intervention Program in Patients with Poor Adherence to rhGH Treatment

hrp0084p3-948 | GH & IGF

Favourable GH Treatment Response in a Young Boy with Achondroplasia

hrp0084p3-949 | GH & IGF

Plexiform Neurofibroma and Demielinisant Lesions in a Patient with GH Deficiency Treated with rGH

hrp0084p3-950 | GH & IGF

Growth, Development and Puberty of Patients with Congenital Multiple Pituitary Hormone Deficiencies

hrp0084p3-951 | GH & IGF

Predictors of Response to rhGH Treatment in 125 Children with Short Stature of Various Aetiologies

hrp0084p3-952 | GH & IGF

Linear Regression Model of Final Height Prediction Based on Pre-Treatment Data in Children with GH Deficiency Treated with GH

hrp0084p3-953 | GH & IGF

Vitamin D Levels and not Vitamin A are Correlated with Height Velocity in Children with GH Deficiency Who are Under GH Treatment

hrp0084p3-954 | GH & IGF

Long-Term Effects of GH Replacement Therapy on Hematopoiesis in GH Deficient Children

hrp0084p3-955 | GH & IGF

Thyroid Function in Children Treated with rhGH for GH Deficiency

hrp0084p3-956 | GH & IGF

A 5-year Follow-up of Adults, with Childhood-Onset GH Deficiency, Treated with GENOTONORM® in France

hrp0084p3-957 | GH & IGF

Somatotropic Pituitary Insufficiency in Kearns-Sayre Syndrome – The Clinical Picture, Genetic Diagnosis and Efficacy of rhGH Therapy

hrp0084p3-958 | GH & IGF

The Correlation between the Increase in IGF1 24 h after the First Injection of GH and the Improved Growth

hrp0084p3-959 | GH & IGF

Late Diagnosis of a Type II/III Mucolipidoses Treated with GH Replacement Therapy

hrp0084p3-960 | GH & IGF

Does Applying Regular Questionnaire to Patients on GH Increase the Compliance?

hrp0084p3-961 | GH & IGF

Characterisation of Children Born Small for Gestational Age within the Australian Indications for GH (GH) Therapy: An OZGROW Analysis

hrp0084p3-962 | GH & IGF

Effectiveness of rhGH Treatment in a Boy with Nephrogenic Diabetes Insipidus

hrp0084p3-963 | GH & IGF

The Easypod™ Connect Observational Study: Comparison of Results from Interim Analyses

hrp0084p3-964 | GH & IGF

Evaluation of the Facility of Use of a New GH Administration Device – Study DAGH2014

hrp0084p3-965 | GH & IGF

Effect of Human Growth Hormone on Growth Rate of Short Stature Children with Low Birth Weight

hrp0084p3-966 | GH & IGF

GH Treatment and First Year Response: A Retrospective Study

hrp0084p3-967 | GH & IGF

Usefulness of Reevaluation of Growth Hormone Secretion During Puberty

hrp0084p3-968 | GH & IGF

Bone Age Maturation in Prader-Willi Syndrome on GH Treatment is Accelerated in Pre-Pubertal Age without Affecting Final Height

hrp0084p3-969 | GH & IGF

Evaluating First Year Response and Final Height to Growth Hormone Treatment in Growth Hormone Deficiency Based on Peak GH Levels on Testing

hrp0084p3-970 | GH & IGF

Growth Hormone Therapy in Children: Predictive Factors and Short-Term and Long-Term Response Criteria in an Italian Cohort

hrp0084p3-971 | GH & IGF

Patients with Childhood Onset Growth Hormone Deficiency Treated with rhGH – Reevaluation in the Transition Period between Childhood and Adulthood – Preliminary Study

hrp0084p3-972 | GH & IGF

Time Trends in Baseline Characteristics (2006–2014) in Short Children with Growth Hormone Deficiency (GHD), Born Small for Gestational Age (SGA) and with Ullrich-Turner Syndrome (TS) Enrolled in Nordinet® International Outcomes Study (IOS) in Germany and Czech Republic

hrp0084p3-973 | GH & IGF

A Patient with an 13q Deletion Syndrome, Important Growth Delay and Somatotropine Insufficiency Undergoing Growth Hormone Therapy–Case Report.

hrp0084p3-974 | GH & IGF

Linear Growth in a Child with Ellis Van Creveld Syndrome: Positive Effect of Growth Hormone Therapy

hrp0084p3-975 | GH & IGF

Factors Effecting Response to Growth Hormone Treatment in Children with Turner Syndrome

hrp0084p3-976 | GH & IGF

Thyroid Function in Children with Prader-Willi Syndrome, the First 12 Months of GH Therapy

hrp0084p3-977 | GH & IGF

Congenital Hypopituitarism and Severe Developmental Delay Associated with Homozygous POU1F1 Mutation

hrp0084p3-978 | GH & IGF

GH Therapy in Lery-Weill Syndrome: Report of Three Cases

hrp0084p3-979 | GH & IGF

The Assessment of Quality of Life and New Technologies for Therapeutic Monitoring in a Cohort of Paediatric Patients Treated with GH

hrp0084p3-980 | GH & IGF

Final Height in Patients with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiencies, Treated with GH

hrp0084p3-981 | GH & IGF

Current Practice in Diagnosis and Treatment of GH Deficiency in Childhood: A Survey from Turkey

hrp0084p3-982 | GH & IGF

Experience of the Use of Genetically Engineered GH ‘Rastan’ by Children in Clinical Practice

hrp0084p3-983 | GH & IGF

GH Therapy in Kuwait: First Report on Characteristics and Response in Treated Children

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more